Neurosense Therapeutics Ltd
NRSN0.810USD
-0.008-1.00%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
19.93MMarket Cap
LossP/E TTM
Neurosense Therapeutics Ltd Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.55
25.93%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its Earnings Per Share (EPS) was -0.549, with a year-on-year change of 25.93%.
What is the net income of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its net income was -10.21M, with a year-on-year change of -1.02%.
What is the net margin of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its Return on Equity (ROE) was -2478.16%, with a year-on-year change of -324.01%.
What is the Return on Assets (ROA) of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its Return on Assets (ROA) was -263.14%, with a year-on-year change of -27.08%.
What is the operating profit of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its operating profit was -9.90M, with a year-on-year change of 17.82%.
What are the current assets of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its current assets were 4.40M, with a year-on-year change of 50.96%.
What are the total assets of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its total assets of Neurosense Therapeutics Ltd were 4.58M, with a year-on-year change of 43.64%.
What are the total liabilities of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its total liabilities of Neurosense Therapeutics Ltd were 1.99M, with a year-on-year change of -59.71%.
What is the total equity of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its total equity of Neurosense Therapeutics Ltd was 2.58M, with a year-on-year change of 246.84%.
What is the net operating income of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its net operating income of Neurosense Therapeutics Ltd was -10.21M, with a year-on-year change of -1.02%.
What is the net investment of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its net investment of Neurosense Therapeutics Ltd was 1.00K, with a year-on-year change of -99.97%.
What is the net financing of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2024 earnings report, its net financing of Neurosense Therapeutics Ltd was 10.91M, with a year-on-year change of 174.54%.
